Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,19410,56,1.86 [1.01-3.42],0.0453780241208408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABHD14B,Protein ABHD14B,22892,70,1.45 [1.01-2.08],0.0465412480912662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",22746,68,1.58 [1.10-2.28],0.0138417309823157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,23437,70,1.64 [1.01-2.67],0.047475258486529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,23048,70,1.99 [1.28-3.11],0.0022837944020295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,20102,59,2.20 [1.18-4.13],0.0134540602733691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22619,68,1.43 [1.03-2.00],0.0347237591287547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,20092,59,3.07 [1.26-7.44],0.0133472143933793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,19647,60,1.47 [1.09-1.97],0.0104870667168555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22746,68,1.33 [1.03-1.72],0.0306898353606616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,23166,69,1.33 [1.02-1.72],0.0331695811721209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23021,68,1.22 [1.01-1.48],0.0415716952360327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALPP,"Alkaline phosphatase, placental type",23054,68,1.23 [1.02-1.50],0.0325873856362965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,23127,70,2.24 [1.32-3.82],0.0028793963998307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANKRD54,Ankyrin repeat domain-containing protein 54,22619,68,1.36 [1.02-1.83],0.0379798934149895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,22655,70,1.32 [1.07-1.64],0.0107118489994676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APOF,Apolipoprotein F,20118,60,0.36 [0.20-0.65],0.000652080207819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,APP,Amyloid-beta precursor protein,23143,69,1.40 [1.02-1.91],0.035601874893508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,19446,57,1.34 [1.01-1.77],0.0447933335838022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARNT,Aryl hydrocarbon receptor nuclear translocator,22757,70,0.46 [0.23-0.91],0.0260266813410808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATOX1,Copper transport protein ATOX1,23228,70,1.46 [1.08-1.98],0.0149344731768191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCR,Breakpoint cluster region protein,23141,70,1.26 [1.00-1.58],0.0486334578630853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,23375,71,1.48 [1.06-2.06],0.0203994678575547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,23141,70,1.77 [1.12-2.79],0.0141944704454775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,23127,70,1.68 [1.13-2.51],0.0104027992173553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,23133,70,1.55 [1.07-2.24],0.0193583899723942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,23366,71,1.97 [1.26-3.09],0.0031609575326817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,19410,56,1.57 [1.04-2.36],0.0310695617951548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD27,CD27 antigen,23228,70,1.59 [1.01-2.51],0.0445206412726105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2AP,CD2-associated protein,23166,69,1.38 [1.00-1.91],0.0466256056206586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19747,59,1.58 [1.05-2.36],0.0274304272851506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,22361,67,2.75 [1.40-5.41],0.0034388726142142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD63,CD63 antigen,22923,70,1.65 [1.08-2.54],0.021549317863277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,19647,60,1.83 [1.11-3.03],0.0181730091281314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,20092,59,2.44 [1.36-4.39],0.0028480167731305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,22757,70,1.32 [1.06-1.64],0.0135922496210246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP290,Centrosomal protein of 290 kDa,19747,59,0.49 [0.26-0.91],0.0252284075086997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLEC7A,C-type lectin domain family 7 member A,23437,70,1.65 [1.06-2.56],0.0273266095563117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLGN,Calmegin,19557,56,1.70 [1.17-2.47],0.0050738809347821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLU,Clusterin,20117,60,1.83 [1.22-2.74],0.0033853402430105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNDP1,Beta-Ala-His dipeptidase,23274,70,1.65 [1.00-2.71],0.0496350676300302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COCH,Cochlin,20092,59,1.87 [1.19-2.95],0.0068565401629611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,23268,69,3.12 [1.32-7.37],0.0093518968008957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,22582,68,0.68 [0.52-0.89],0.0045545333308345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,22963,70,1.81 [1.29-2.54],0.0005439683057576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,20118,60,1.82 [1.09-3.05],0.022623572369792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSH1,Chorionic somatomammotropin hormone 1,20118,60,2.16 [1.04-4.48],0.0386795022916701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,23230,70,2.45 [1.31-4.56],0.0048494501355729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST7,Cystatin-F,23173,71,1.21 [1.02-1.43],0.0315859702201975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSL,Cathepsin L1,23166,69,2.71 [1.26-5.84],0.0110608266097615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,23437,70,2.03 [1.09-3.78],0.0266548983647006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSS,Cathepsin S,18233,54,3.02 [1.05-8.70],0.0401988737512729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,19396,57,1.38 [1.09-1.74],0.0066209147323407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,23228,70,1.57 [1.09-2.26],0.0160786460312521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DMP1,Dentin matrix acidic phosphoprotein 1,19543,57,0.64 [0.44-0.93],0.0204682006237313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,23303,71,1.51 [1.15-1.99],0.0028507643985035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,20053,58,2.19 [1.13-4.23],0.019631860422753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DTX3,Probable E3 ubiquitin-protein ligase DTX3,23054,68,2.16 [1.06-4.39],0.033038247761515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20092,59,1.38 [1.03-1.83],0.0281104517183226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNA4,Ephrin-A4,22923,70,2.09 [1.21-3.59],0.0080560495762811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFNB2,Ephrin-B2,19557,56,1.41 [1.05-1.90],0.0237649950045792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EPHA10,Ephrin type-A receptor 10,22655,70,0.56 [0.35-0.88],0.0128368217329864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERC2,ERC protein 2,19557,56,1.34 [1.05-1.70],0.016443905849842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F3,Tissue factor,23218,70,0.43 [0.19-0.98],0.0452172805363049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP4,"Fatty acid-binding protein, adipocyte",23457,69,1.69 [1.16-2.46],0.005979482255768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,23327,69,1.53 [1.09-2.15],0.0141569185519035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF12,Fibroblast growth factor 12,19503,59,0.32 [0.11-0.91],0.0329453028493865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF21,Fibroblast growth factor 21,23340,71,1.21 [1.04-1.42],0.0166308191556403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,23228,70,2.89 [1.24-6.69],0.0134949561590795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,20118,60,1.54 [1.09-2.20],0.0157054168179446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FSHB,Follitropin subunit beta,19543,57,1.79 [1.31-2.43],0.0002054517868914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,19647,60,1.59 [1.11-2.29],0.0118358972062538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23054,68,2.19 [1.04-4.61],0.0386271140729244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,20044,58,1.33 [1.15-1.54],0.0001374920022377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,23457,69,2.12 [1.53-2.94],6.819102663136367e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,22655,70,1.82 [1.14-2.92],0.0127027294389513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,23138,69,1.71 [1.21-2.42],0.0022320263067787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,19396,57,1.75 [1.26-2.45],0.0009454347632239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GNLY,Granulysin,23180,69,1.57 [1.08-2.26],0.0170502825488971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,20022,60,1.58 [1.17-2.13],0.0027876240808772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRN,Progranulin,23055,68,2.71 [1.35-5.44],0.005018427865741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",23054,68,1.50 [1.11-2.03],0.0081690368875951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19747,59,1.32 [1.03-1.69],0.0307127161756264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,23437,70,1.88 [1.08-3.26],0.0255029542828428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,23366,71,1.22 [1.04-1.43],0.0160851549411223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,19647,60,2.43 [1.01-5.85],0.0481043753304257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23063,69,2.13 [1.31-3.46],0.0023098349297647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,22860,70,1.67 [1.09-2.55],0.0190605296535661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23366,71,1.86 [1.27-2.72],0.0013194005318805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSP90B1,Endoplasmin,22546,70,1.34 [1.08-1.66],0.0076395601341955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23012,70,2.03 [1.04-3.98],0.0379246989238926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19550,57,2.12 [1.27-3.54],0.0042766363356111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20102,59,0.42 [0.21-0.83],0.0127604159598998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP3,Insulin-like growth factor-binding protein 3,23274,70,0.54 [0.30-0.97],0.0391460183690228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,23166,69,2.06 [1.17-3.60],0.0116224033103733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IKZF2,Zinc finger protein Helios,22619,68,0.61 [0.41-0.92],0.0182254056498274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,22757,70,1.74 [1.01-3.00],0.044768370871049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,22757,70,0.56 [0.32-0.99],0.0466397307668361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL32,Interleukin-32,23141,70,1.52 [1.00-2.31],0.0490444173558962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,20022,60,1.65 [1.11-2.46],0.0130658706247815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IPCEF1,Interactor protein for cytohesin exchange factors 1,22923,70,1.29 [1.02-1.64],0.036022127655673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGA11,Integrin alpha-11,23141,70,0.45 [0.25-0.84],0.0114622031766454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIF22,Kinesin-like protein KIF22,19410,56,1.43 [1.14-1.80],0.0021202451247746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,23166,69,0.56 [0.33-0.96],0.0351768481480963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,22619,68,0.85 [0.73-1.00],0.0465043111087125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",23054,68,1.30 [1.03-1.65],0.0277049842632304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT8,"Keratin, type II cytoskeletal 8",19446,57,1.37 [1.11-1.69],0.0031364530380643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,20092,59,1.83 [1.35-2.48],8.666206324609765e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS1,Galectin-1,23166,69,1.87 [1.11-3.16],0.019517057342474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIF,Leukemia inhibitory factor,22655,70,0.54 [0.32-0.89],0.0165107719349029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23457,69,2.35 [1.11-4.99],0.0254387533117087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23346,69,2.15 [1.13-4.08],0.0188888738123986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22757,70,1.87 [1.20-2.91],0.0054407605609647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,22347,68,1.45 [1.04-2.03],0.0279233981064156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP3L,Microfibrillar-associated protein 3-like,19557,56,0.48 [0.24-0.94],0.0316416944794396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MME,Neprilysin,23054,68,1.40 [1.08-1.80],0.0098187538165951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP12,Macrophage metalloelastase,23198,70,1.49 [1.04-2.13],0.028324155979765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,20118,60,2.99 [1.38-6.47],0.0053838049609624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,23375,71,1.87 [1.21-2.87],0.0044853358453995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,22757,70,1.36 [1.07-1.72],0.0112906782222414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCAN,Neurocan core protein,23375,71,0.45 [0.26-0.76],0.0026685177663754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCLN,Nicalin,22757,70,0.43 [0.21-0.88],0.0210135385038894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEB,Nebulin,19410,56,1.87 [1.27-2.74],0.0014477866164083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,22588,70,1.95 [1.42-2.68],3.481838399957073e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23141,70,1.24 [1.00-1.52],0.0465035199775164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFIC,Nuclear factor 1 C-type,20053,58,0.30 [0.11-0.82],0.0191986632697122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFKBIE,NF-kappa-B inhibitor epsilon,22619,68,1.48 [1.00-2.19],0.0492476370781035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,23203,70,1.80 [1.03-3.13],0.0375689245351037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,19760,57,2.41 [1.47-3.94],0.00048535942066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,23228,70,1.54 [1.09-2.16],0.0141504151674211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,20053,58,1.65 [1.00-2.71],0.0493676650699423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20053,58,0.69 [0.48-0.99],0.0457566072548587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PARP1,Poly [ADP-ribose] polymerase 1,23141,70,1.28 [1.01-1.63],0.0424761729464348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCARE,Photoreceptor cilium actin regulator,19446,57,0.61 [0.37-0.99],0.0450981109382663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19608,60,1.70 [1.08-2.68],0.0230894083603602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZD2,PDZ domain-containing protein 2,19410,56,1.42 [1.01-2.01],0.0460706547887362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PF4,Platelet factor 4,19966,60,1.31 [1.03-1.66],0.0276744908008664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PGLYRP1,Peptidoglycan recognition protein 1,23346,69,1.61 [1.05-2.48],0.0299578884385716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRA,Paired immunoglobulin-like type 2 receptor alpha,23180,69,1.71 [1.03-2.82],0.0363236152317503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PILRB,Paired immunoglobulin-like type 2 receptor beta,23166,69,1.60 [1.07-2.38],0.0211838126969674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,23228,70,2.32 [1.15-4.68],0.0189388196358615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,23343,69,2.68 [1.22-5.88],0.0140468289830032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,POSTN,Periostin,20102,59,0.44 [0.23-0.86],0.0169531821148416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PPY,Pancreatic prohormone,23102,70,1.31 [1.08-1.59],0.0069271907101882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRKCQ,Protein kinase C theta type,22757,70,0.47 [0.26-0.87],0.0161543202917495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS2,Trypsin-2,23274,70,1.56 [1.15-2.12],0.0039798212423831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PRSS8,Prostasin,23055,71,1.61 [1.00-2.59],0.0489741596354759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,19915,58,2.60 [1.54-4.38],0.0003316884047621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSMA1,Proteasome subunit alpha type-1,22619,68,0.54 [0.31-0.93],0.0270929986891742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,20092,59,2.84 [1.29-6.27],0.0095424898115618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22539,69,1.46 [1.03-2.08],0.0336958159301139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,23189,69,2.71 [1.33-5.54],0.0060303213381009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QSOX1,Sulfhydryl oxidase 1,19712,59,1.49 [1.06-2.10],0.0234390107335631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19446,57,1.50 [1.20-1.88],0.0003331631768093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,22619,68,1.67 [1.12-2.47],0.0108907655721733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES2,Retinoic acid receptor responder protein 2,23312,70,1.50 [1.05-2.14],0.0261278063355645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RASA1,Ras GTPase-activating protein 1,22655,70,0.47 [0.24-0.91],0.0251933876275134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,23054,68,1.44 [1.00-2.06],0.047642089198694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REG3A,Regenerating islet-derived protein 3-alpha,23457,69,1.48 [1.11-1.97],0.00698455074365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,20118,60,2.29 [1.20-4.34],0.0115076676852022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,19983,60,2.06 [1.39-3.04],0.0002863442357768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNF168,E3 ubiquitin-protein ligase RNF168,19503,59,0.37 [0.17-0.81],0.0126904407430163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A16,Protein S100-A16,22613,70,0.61 [0.42-0.88],0.0092129741361085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAA4,Serum amyloid A-4 protein,20117,60,1.73 [1.21-2.47],0.0025471052185861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,22503,68,2.24 [1.34-3.76],0.0021503598137585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,23304,70,1.73 [1.15-2.59],0.0083156859509189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,23166,69,1.65 [1.02-2.66],0.0419045965951245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA3G,Semaphorin-3G,19647,60,1.98 [1.30-3.03],0.0015756466481671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,23381,69,1.80 [1.01-3.23],0.0476584385701037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINB9,Serpin B9,22963,70,2.02 [1.08-3.77],0.0275543155583096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",23212,71,1.28 [1.00-1.64],0.0488823710395603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,23141,70,1.77 [1.07-2.95],0.0275425783467185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19503,59,0.56 [0.32-0.96],0.0352263370123304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,22619,68,1.73 [1.11-2.70],0.0163024858814185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF7,SLAM family member 7,23141,70,1.55 [1.12-2.15],0.0077334416214451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,22655,70,1.36 [1.01-1.84],0.0435021471933407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK1,Serine protease inhibitor Kazal-type 1,23180,69,1.68 [1.08-2.63],0.0226072475995175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK4,Serine protease inhibitor Kazal-type 4,23141,70,1.58 [1.19-2.08],0.0013320640148583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINK6,Serine protease inhibitor Kazal-type 6,23366,71,1.79 [1.20-2.67],0.0044227460422977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,23248,71,1.87 [1.11-3.14],0.0176910262594661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SUSD1,Sushi domain-containing protein 1,22746,68,1.53 [1.02-2.31],0.0409983577855579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SV2A,Synaptic vesicle glycoprotein 2A,19557,56,1.42 [1.03-1.95],0.0301392776413937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TAGLN3,Transgelin-3,19396,57,0.63 [0.41-0.95],0.0276291686177829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,19747,59,1.74 [1.31-2.29],0.0001034626558325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,23069,69,1.37 [1.10-1.71],0.0053395443588547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,23212,71,1.46 [1.06-2.01],0.0221779048321106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,19410,56,1.21 [1.01-1.45],0.0378684500333665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,22938,70,2.34 [1.27-4.30],0.0062277503529285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22963,70,2.02 [1.21-3.37],0.0068852175145502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23437,70,1.67 [1.02-2.73],0.0407150360436154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23165,71,2.03 [1.48-2.78],1.089851943031208e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23165,71,2.04 [1.12-3.72],0.0201525327911463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19647,60,1.94 [1.13-3.34],0.0168855721931821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TREH,Trehalase,20102,59,1.44 [1.02-2.06],0.0408727948671383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TRIM24,Transcription intermediary factor 1-alpha,19712,59,1.44 [1.03-2.00],0.0312035976831072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TSLP,Thymic stromal lymphopoietin,22746,68,0.60 [0.37-0.96],0.0329928796064265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXK,Tyrosine-protein kinase TXK,19747,59,0.50 [0.28-0.89],0.0186095730687717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23180,69,1.56 [1.01-2.41],0.0441801668736292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UBQLN3,Ubiquilin-3,19410,56,1.40 [1.00-1.96],0.0499076627937567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UMOD,Uromodulin,23376,69,0.62 [0.43-0.88],0.0082244306379517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,20092,59,1.29 [1.00-1.67],0.0464432734940071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,23363,70,1.61 [1.16-2.23],0.0042239905691738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VNN2,Vascular non-inflammatory molecule 2,23054,68,1.67 [1.03-2.71],0.0361529485918781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSNL1,Visinin-like protein 1,20044,58,1.66 [1.04-2.65],0.0336011157972798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,WFDC2,WAP four-disulfide core domain protein 2,22005,69,1.77 [1.15-2.73],0.0092898751366263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20022,60,1.54 [1.07-2.21],0.0191285501721632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZPR1,Zinc finger protein ZPR1,19446,57,1.24 [1.02-1.51],0.0335699376959012
